Researchgate profileJulie HENRIQUES is a research engineer in biostatistics. She passed in 2010 a master’s degree in statistical modeling at the University of Franche-Comté. During the master’s degree’s internship in the biostatistics service of the Hospices Civils of Lyon, she realized a study on the correction of survival estimates in the context of loss to follow-up in HIV cohort . She worked as independent statistician for 5 years and participated to projects in many area such as financial times series, reservoir computing or EEG signal processing.
In 2015, she joined the Methodology and quality of life unit in Oncology (UMQVC) at the University hospital of Besancon.
Latest publications
AbstractOverview of biliary tract cancer management practices in France: results of the ACABi national survey...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : Bull Cancer
AbstractMismatch repair-deficient (dMMR) and/or microsatellite instability-high (MSI) colorectal cancers (CRC) represent...
Posted by : Dr. Dewi VERNEREY, Mme. Julie HENRIQUES
Journal name : Int J Cancer
AbstractHigh-risk HPV (hrHPV) testing has been implemented as a primary screening tool for cervical cancer in numerous...
Posted by : Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE, Mme. Julie HENRIQUES
Journal name : Cancers (Basel)
ABSTRACTBackground: Cardiac toxicity with a decrease of the left ventricular ejection fraction (LVEF) is the main side...
Posted by : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Journal name : The Breast
AbstractBackground: To evaluate the objective response rate (ORR) at 2 months of treatment with regorafenib...
Posted by : Mme. Julie HENRIQUES
Journal name : Cancer Imaging
AbstractSmall bowel adenocarcinoma (SBA) is a rare tumour. We conducted a prospective cohort to describe the prevalence,...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : Int J Cancer
AbstractIntroduction: Regorafenib (R) and trifluridine/tipiracil (FTD/TPI) are of proven efficacy in metastatic...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : Clinical colorectal cancer
AbstractAnti-EGFR efficacy in patients with microsatellite instability (MSI) metastatic colorectal cancer (mCRC)...
Posted by : Dr. Dewi VERNEREY, Mme. Julie HENRIQUES
Journal name : J Natl Cancer Inst
AbstractBackground: Patients with RAS wild-type (WT) nonresectable metastatic colorectal cancer (mCRC) may receive...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : Oncologist
AbstractIn metastatic pancreatic adenocarcinoma, a high neutrophil-to-lymphocyte ratio (NLR) at diagnosis is a marker of...
Posted by : Dr. Dewi VERNEREY, Mme. Julie HENRIQUES
Journal name : Clin Res Hepatol Gastroenterol